MAS1 and myeloid sarcoma: For their part, Dalmasso et al. [23] described a significant decrease in lectin expression in the MS group, whereas the expression of perlecan, angiotensinogen mRNA, and other components of the renin-angiotensin system (such as MAS1 or neprilysin) did not show relevant variations.